1. Home
  2. NVST vs WGS Comparison

NVST vs WGS Comparison

Compare NVST & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envista Holdings Corporation

NVST

Envista Holdings Corporation

HOLD

Current Price

$29.47

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$91.09

Market Cap

4.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVST
WGS
Founded
2018
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.6B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
NVST
WGS
Price
$29.47
$91.09
Analyst Decision
Buy
Strong Buy
Analyst Count
14
8
Target Price
$23.85
$138.13
AVG Volume (30 Days)
3.5M
862.3K
Earning Date
02-05-2026
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.28
0.07
Revenue
$2,719,500,000.00
$402,190,000.00
Revenue This Year
$2.81
$41.17
Revenue Next Year
$3.54
$23.94
P/E Ratio
$104.02
$1,146.19
Revenue Growth
8.32
50.50
52 Week Low
$14.22
$55.17
52 Week High
$29.28
$170.87

Technical Indicators

Market Signals
Indicator
NVST
WGS
Relative Strength Index (RSI) 79.71 34.96
Support Level $22.75 $81.55
Resistance Level $24.48 $101.94
Average True Range (ATR) 0.96 6.78
MACD 0.45 -0.11
Stochastic Oscillator 95.26 38.30

Price Performance

Historical Comparison
NVST
WGS

About NVST Envista Holdings Corporation

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Share on Social Networks: